Laboratorio de Química Inorgánica y Organometálica, Departamento de Química Analítica e Inorgánica, Facultad de Ciencias Químicas, Universidad de Concepción, Concepción, Chile.
Dipartimento Neurofarba, Sezione di Scienze Farmaceutiche, Università degli Studi di Firenze, Firenze, Italy.
J Enzyme Inhib Med Chem. 2020 Dec;35(1):622-628. doi: 10.1080/14756366.2020.1724995.
A series of bio-organometallic-hydrazones of the general formula [{(η-CH)-C(R)=N-N(H)-CH-4-SONH}]MLn(MLn = Re(CO), Mn(CO), FeCp; R=H, CH) were prepared by reaction of formyl/acetyl organometallic precursors with 4-hydrazino-benzenesulphonamide. All compounds were characterized by conventional spectroscopic techniques (infra-red, H and C NMR, mass spectrometry and elemental analysis). Biological evaluation as carbonic anhydrase (CA, EC 4.2.1.1) inhibitors agents was carried out using four human/h) isoforms, hCA I, II, IX and XII. The cytosolic isoforms hCA I and II were effectively inhibited by almost all derivatives with inhibition constants of 1.7-22.4 nM. Similar effects were observed for the tumour-associated transmembrane isoform hCA XII (Ks of 1.9-24.4 nM). hCA IX was less sensitive to inhibition with these compounds. The presence of bio-organometallic or metallo-carbonyl moieties in the molecules of these CAIs makes them amenable for interesting pharmacologic applications, for example for compounds with CO donating properties.
一系列通式为[{(η-CH)-C(R)=N-N(H)-CH-4-SONH}]MLn 的生物有机金属腙(MLn=Re(CO)、Mn(CO)、FeCp;R=H、CH)通过甲酰基/乙酰基有机金属前体与 4-肼基苯磺酰胺反应制备。所有化合物均通过常规光谱技术(红外、H 和 C NMR、质谱和元素分析)进行了表征。使用四种人源/同型(h)CA(CA,EC 4.2.1.1),即 hCA I、II、IX 和 XII,对生物有机金属腙作为碳酸酐酶(CA)抑制剂的活性进行了评估。细胞溶质同工酶 hCA I 和 II 被几乎所有衍生物有效抑制,抑制常数为 1.7-22.4 nM。类似的效果也观察到在肿瘤相关的跨膜同工酶 hCA XII 中(Ks 为 1.9-24.4 nM)。这些 CAIs 中的生物有机金属或金属羰基部分使它们适合于有趣的药理应用,例如具有 CO 供体性质的化合物。